| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |